Eize De Boer showed us what it takes to realize a new facility for Batavia Biosciences designed for…
Aaron Ogdahl28 October 2022
Featured article
All news & events
BARCELONA, Spain — September 15, 2022- Veeva Systems (NYSE: VEEV) today announced Batavia Biosciences selected Veeva Vault Quality Suite to optimize its global quality assurance (QA), unifying content, processes, and…
Batavia Biosciences would like to congratulate IAVI on their press release, as today they've announced volunteers in Monrovia, Liberia have been vaccinated with IAVI’s novel vaccine candidate against Lassa fever virus…
Leiden, The Netherlands, June 28, 2022 – Today, Batavia Biosciences announces that it will extend its CDMO services portfolio (R&D and clinical manufacturing) to include commercial manufacturing services. The company…
It is with great enthusiasm and excitement that we would like to congratulate Leiden University Medical Center and the research team on their recent accomplishment using the lentivirus. Researchers have successfully…
Leiden, The Netherlands, June 14, 2022 – Today, Batavia Biosciences announces the expansion of its headquarters and R&D capacities in the Netherlands. The infrastructure increases capacity with another 22,500 sq.…
Washington, April 20, 2022 - Batavia Biosciences was honored this week during the Vaccine Industry Excellence (ViE) Awards show at the World Vaccine Congress with the award for Best Production/Process…
With Ron van Eijsden heading the Sales and Business Development team, Batavia expands its Management Team and reinforces its sales activities to support the ambitious expansion plans. In 2021, Batavia…
Woburn, MA, USA, March 22, 2022 -- Batavia Biosciences Inc. announces today that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). As an industry partner, Batavia…
Batavia Biosciences is proud to announce that CJ CheilJedang (Seoul, South Korea) has selected the company to advance its position in the red biotechnology field. In a press release today,…
Leiden, The Netherlands, October 28, 2021 – Batavia Biosciences is pleased to announce today that they are the manufacturing partner of IAVI’s Sudan ebolavirus vaccine candidate, rVSV∆G-SUDV-GP. The clinical trial…
Today, Batavia Biosciences announces the expansion of its process development facilities in Woburn, MA, United States to accommodate the increasing market demand for viral vectors. Chris Yallop, COO at Batavia…
Leiden, The Netherlands, July 14, 2021 – Batavia Biosciences announces today that they have successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa fever vaccine candidate,…
Leiden, 6 July 2021 – Today, Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines based on breakthrough genetic engineering. Under the agreement, Batavia…
We would like to introduce you to our newest team member: kingfisher Alec! Alec is Batavia Biosciences' official mascot. In this post, we would like to explain how we found…
Leiden, 3 December 2020 – KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing organization…
Saint-Herblain, France, and Leiden, Netherlands, June 15, 2020 – Batavia Biosciences (“Batavia”) and Valneva Sweden AB, the Swedish subsidiary of Valneva SE (“Valneva”) today announced that they have entered into…
As the COVID-19 pandemic continues, we would like to update you on our business status. As a company at the forefront of epidemic preparedness, staying operational is critical as it…
The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines PHILADELPHIA — (April 29, 2020) — The Wistar Institute and Batavia Biosciences announce the…
Leiden, April 15, 2020 – Immutep and Batavia Biosciences announce today that they have successfully generated a high yielding cell line for an IgG4-based antibody for LAG-3 immunotherapy for autoimmune…
Mutual expertise drives innovations to address supply issues for vaccines for outbreak pathogens NEW YORK — MARCH 5, 2020 — IAVI, a nonprofit scientific research organization dedicated to addressing urgent,…
Ten years ago, Christopher Yallop and Menzo Havenga incorporated Batavia Biosciences at the chamber of commerce in the Netherlands. The company started operations on January 1, 2010 at that time…
We are proud to announce that our CEO, Menzo Havenga, has won the CEO Today Healthcare Award 2019. Menzo is praised for his leading role in the biopharmaceutical medicines development…
Leiden, the Netherlands, Nov 12, 2019 – We are proud to announce that we have partnered with IAVI under an award they have received from the US Defense Threat Reduction Agency…
Batavia Biosciences has once again been selected as National Winner in the award category 'Innovation' in The European Business Awards, Europe’s largest business competition. The award to Batavia was granted…
Leiden, the Netherlands, Sep 16, 2019 – Today, Batavia Biosciences announces it received a grant of $6.5 million from the Bill & Melinda Gates Foundation to develop a manufacturing process…
Leiden, 3 September 2019 – Today, Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for…
Leiden, 4 Jul 2019 – Today, Batavia Biosciences announces it received a follow-up grant of $2.2 million from PATH – a global organization dedicated to health equity – to develop…
Grant from the Bill & Melinda Gates Foundation will support Univercells and partner Batavia Biosciences to develop a cost-effective manufacturing process and proceed towards the successful commercialization of measles and…
Leiden, the Netherlands, May 14, 2019 – Batavia Biosciences announced today that it will work together in a consortium including the European Vaccine Initiative and Stanford University, icddr,b, and headed…
The European Union has awarded €15 million to the CardioReGenix consortium, as part of the Horizon2020 program. The research program is initiated to develop new gene therapy approaches for the…
Leiden, The Netherlands, February 25, 2019 – Batavia Biosciences announced today that it received a $13.2 million grant from the Bill & Melinda Gates Foundation to manufacture clinical-grade inactivated polio…
Univercells, a business-to-business provider focused on increasing the availability of affordable biologics to address global health challenges, announced today the commercial launch of its proprietary NevoLine™ bioproduction system for vaccines.…
Leiden, December 11th, 2018 – Batavia Biosciences announces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of…
We are proud to announce that Batavia Biosciences has again been awarded with an FD Gazelle Award 2018 by the leading Dutch financial newspaper, Financieel Dagblad as one of the…
We are pleased to announce that Dr. Menzo Havenga has been awarded the title CEO OF THE YEAR 2018- CONTRACT DEVELOPMENT AND MANUFACTURING. The European CEO Awards organization celebrates global business leaders that are…
Today, GHP Announces Winners of the Healthcare & Pharmaceutical Awards 2018. We are very proud to announce that Batavia Biosciences has been awarded “Best Biopharmaceutical Contract Development & Manufacturing Company 2018”.…
We are very proud that our CEO, Menzo Havenga, has been decorated in the Order of Orange-Nassau for his scientific achievements and his contributions to society. The Order of Orange-Nassau…
Leiden, 22 March 2018 - Leiden University has received a prestigious TTW-grant from the Netherlands Organization for Scientific Research (NWO) to collaborate with private partners ZoBio, and Batavia Biosciences to…
Brussels, 2 March 2018 - Batavia Biosciences has been selected as most innovative company in the Netherlands during an exclusive event held at the British Residence in Brussels for The…
Leiden, 16 January 2018 – Today Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The…
We are very proud that the prestigious organization "CEO Monthly" has awarded the title of "CEO of the Year 2017 - Netherlands" to our Chief Executive Officer, Menzo Havenga. Menzo…
Platform technologies facilitate development and accelerate commercialization of protein therapeutics. Speed to market is essential in the biopharmaceutical industry today. Manufacturers are seeking mechanisms for increasing efficiencies and reducing costs without compromising the safety and…
Yesterday, Batavia Biosciences has been awarded with an FD Gazelle Award 2017 by the leading Dutch financial newspaper, Financieel Dagblad as one of the fastest growing mid-sized companies of the…
Leiden, 16 October 2017 – Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands…
An international consortium, headed by the group of Prof. Dr. Frank Staal (Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre) has been awarded a €6 million grant from…
Our Director Operations, Marco Cacciuttolo, presented interesting new case studies for our STEP® Technology at the PEGS summit in Boston . For various 'difficult to express proteins' Batavia Biosciences was able to…
Univercells and consortium partners Batavia Biosciences and Natrix Separations selected by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries Brussels, Belgium, December 15, 2016 – Univercells announced…
Leiden/Woburn, 21 September 2016 - Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable…
Advanced cell-line technology could reduce costs of vaccine production Leiden, The Netherlands, and Woburn, MA, 9th June 2016 Batavia Biosciences is committed to increase vaccine availability and affordability for the developing…
Date: Nov 1-3 Location: Frankfurt, Germany Contact: Pieter-Jan Vos It’s time for one of the best bioprocessing events of the year! Come join us at CPHI Frankfurt at Booth #91G03.…
Date: 24 - 26 October 2022 Location: Leipzig, Germany Contact: Pieter-Jan Vos Are your joining us at the BIO-Europe? Our team looks forward to meeting you in person again at…
Date: 11-14 October Location: Edinburgh, Scotland Contact: Pieter-Jan Vos Meet us at the 29th European Society of Gene and Cell Therapy’s (ESGCT) Annual Meeting in Edinburgh, Scotland. We will be…
Date: 11-14 October Location: Barcelona, Spain Contact: Bjorn te Boekhorst Meet us at the World Vaccine Congress, an award-winning series of conferences and exhibitions that have grown to become the largest and…
Date: 16-19 May Location: Washington, USA Contact: Bjorn te Boekhorst Meet us at the 25th American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting in Washington D.C. from May…
Date: 17- 20 May 2022 Location: Vienna, Austria Contact: Pieter-Jan Vos Will you be joining us at BPI Europe? Our team looks forward to meeting you in person again at…
Date: 28 - 30 March 2022 Location: Basel, Switzerland Contact: Pieter-Jan Vos Are your joining us at the BIO Europe Spring event? Our team looks forward to meeting you in…
Date: 18 - 21 April 2022 Location: Washington, USA Contact: Bjorn te Boekhorst It’s time for the most important vaccine event of the year! Come join us at the World…
Date: 10 - 13 October 2022 Location: Barcelona, Spain Contact: Pieter-Jan Vos We will be at the World Vaccine Congress in Barcelona. Our Director Project Management, Ahd Hamidi, will give…
Date: 30 November - 2 December 2021 Location: San Diego, CA Contact: Björn te Boekhorst Meet us at the World Vaccine & Immunotherapy congress November 30 to December 2, 2021…
